Alert detail
FDA Approval: ROCURONIUM (ROCURONIUM BROMIDE) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA217472Specialty: Multi-specialtyAdded: 7/18/2026Effective: June 9, 2025billing update
What changed
New manufacturer rocuronium IV; verify NDC maps to existing J-code.
Who’s affected: Multi-specialty billing teams · Effective: June 9, 2025
Affected codes
CodesJ2704
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 1 billing code.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.